Jefferies Group’s bluebird bio BLUE Stock Holding History

Jefferies Group’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-463	Closed	-$181K	–	1682
2021 Q1	$181K	Buy	+463	New	+$228K	﹤0.01%	1374
2020 Q2	–	Sell	-584	Closed	-$347K	–	1358
2020 Q1	$347K	Buy	+584	New	+$569K	﹤0.01%	1471
2019 Q4	–	Sell	-260	Closed	-$283K	–	2576
2019 Q3	$309K	Sell	260 -111	-30%	-$170K	﹤0.01%	2165
2019 Q2	$611K	Sell	371 -208	-36%	-$360K	﹤0.01%	1562
2019 Q1	$1.18M	Buy	+579	New	+$1.02M	0.01%	1192
2018 Q3	–	Sell	-1,096	Closed	-$2.23M	–	2408
2018 Q2	$2.23M	Buy	1,096 +1,003	+1,078%	+$2.29M	0.01%	838
2018 Q1	$205K	Buy	+93	New	+$237K	﹤0.01%	1966
2016 Q3	–	Sell	-115	Closed	-$83.3K	–	2233
2016 Q2	$65K	Buy	+115	New	+$65.1K	﹤0.01%	1978
2015 Q4	–	Sell	-564	Closed	-$625K	–	2287
2015 Q3	$625K	Buy	564 +562	+28,100%	+$1.02M	﹤0.01%	1413
2015 Q2	$4K	Hold	2	–	–	﹤0.01%	3025
2015 Q1	$3K	Buy	+2	New	+$2.64K	﹤0.01%	2016

Other funds holding BLUE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Jefferies Group's BLUE Position: Q2 2021 in Review

Jefferies Group sold out of bluebird bio (BLUE) in Q2 2021, closing a stake of 463 shares — an estimated $181K sold.

Jefferies Group first reported a position in BLUE in Q1 2015 and held it in 11 quarters. The position peaked at $2.23M in Q2 2018. 232 funds tracked by Wall St. Rank hold BLUE as of Q2 2021.

Jefferies Group reported no remaining bluebird bio position as of Q2 2021 after selling out during the quarter.
Jefferies Group sold 463 bluebird bio shares in Q2 2021, an estimated $181K.
Jefferies Group first reported a position in bluebird bio in Q1 2015 and held it in 11 quarters.
Jefferies Group's bluebird bio position peaked at $2.23M in Q2 2018.
232 funds tracked by Wall St. Rank held bluebird bio as of Q2 2021.

Based on Jefferies Group's 13F filing for Q2 2021, filed 16 Aug 2021.